Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Autoimmune Diseases”

1,673 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,673 results

Not applicableUnknownNCT06119763
What this trial is testing

AntiDFS70 Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 50
Not applicableLooking for participantsNCT04265144
What this trial is testing

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Who this might be right for
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux 500
Not applicableNot Yet RecruitingNCT06588192
What this trial is testing

Renal Survival in Patients with Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 97
Not applicableLooking for participantsNCT06417502
What this trial is testing

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Who this might be right for
Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital 20,000
Testing effectiveness (Phase 2)Study completedNCT02633163
What this trial is testing

Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Not applicableActive Not RecruitingNCT07102238
What this trial is testing

Lupus Arthritis: Muscoloskeletal Ultrasound as Clinical Outcome of Peripheral Blood and Synovial Deep Phenotyping

Who this might be right for
Systemic Lupus Erythematosus
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 269
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Large-scale testing (Phase 3)Study completedNCT00712933
What this trial is testing

A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 738
Not applicableStudy completedNCT01176643
What this trial is testing

Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
McGill University Health Centre/Research Institute of the McGill University Health Centre 57
Testing effectiveness (Phase 2)Ended earlyNCT00732940
What this trial is testing

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 56
Testing effectiveness (Phase 2)Looking for participantsNCT07089121
What this trial is testing

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Who this might be right for
Childhood-onset Systemic Lupus ErythematousANCA-Associated Vasculitis (AAV)Juvenile Myasthenia Gravis+1 more
Cartesian Therapeutics 50
Early research (Phase 1)Looking for participantsNCT06881290
What this trial is testing

Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group 20
Not applicableStudy completedNCT00483613
What this trial is testing

Effects of Treatment of Chronic Stress in Patients With Lupus

Who this might be right for
Systemic Lupus Erythematosus
University Hospital Virgen de las Nieves 45
Not applicableLooking for participantsNCT06503224
What this trial is testing

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
The First Affiliated Hospital of University of Science and Technology of China 18
Not applicableStudy completedNCT03206359
What this trial is testing

GADD34 and Type I IFN Response Genes in SLE

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Grenoble 90
Not applicableStudy completedNCT01689350
What this trial is testing

A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Who this might be right for
Systemic Lupus Erythematosus
Sun Yat-sen University 92
Large-scale testing (Phase 3)Not Yet RecruitingNCT04871191
What this trial is testing

Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis

Who this might be right for
Granulomatosis with PolyangiitisAnti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Assistance Publique - Hôpitaux de Paris 42
Early research (Phase 1)Looking for participantsNCT07403097
What this trial is testing

Study of CD19 CAR-T Therapy for Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd 18
Load More Results